| # | Drug | Count |
|---|---|---|
| 0 | BUDESONIDE | 68 |
| 1 | METHOTREXATE SODIUM | 51 |
| 2 | SOMATROPIN | 47 |
| 3 | METHOTREXATE | 39 |
| 4 | ETANERCEPT | 37 |
| 5 | TOCILIZUMAB | 31 |
| 6 | ANAKINRA | 30 |
| 7 | ALEMTUZUMAB | 23 |
| 8 | FLUDARABINE PHOSPHATE | 22 |
| 9 | ADALIMUMAB | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOLMETIN SODIUM | 1 | 0.0059 |
| 1 | TREOSULFAN | 11 | 0.0040 |
| 2 | SMOFLIPID | 2 | 0.0023 |
| 3 | BECLOMETHASONE DIPROPIONATE | 12 | 0.0021 |
| 4 | MARALIXIBAT CHLORIDE | 2 | 0.0020 |
| 5 | ANAKINRA | 30 | 0.0018 |
| 6 | BARICITINIB | 5 | 0.0016 |
| 7 | DIAZOXIDE | 1 | 0.0014 |
| 8 | MECASERMIN | 1 | 0.0012 |
| 9 | ALEMTUZUMAB | 23 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 109 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 45 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 39 |
| 3 | Recombinant Human Growth Hormone [EPC] | 39 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 31 |
| 5 | Interleukin-1 Receptor Antagonist [EPC] | 30 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 23 |
| 7 | Azole Antifungal [EPC] | 15 |
| 8 | Retinoid [EPC] | 12 |
| 9 | Macrolide Antimicrobial [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 30 | 0.0018 |
| 1 | Recombinant Human Growth Hormone [EPC] | 39 | 0.0018 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 23 | 0.0012 |
| 3 | Lipid Emulsion [EPC] | 2 | 0.0008 |
| 4 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 5 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 6 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 7 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0003 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 31 | 0.0002 |